For patients with heart failure with preserved ejection fraction (HFpEF), endovascular treatment (EVT) improves left ...

Finerenone has been shown to significantly reduce the risk for cardiovascular death in patients with heart failure in results from the FINEARTS-HF trial.

In addition to improving heart failure symptoms, finerenone reduced the onset of new type 2 diabetes in patients with mildly ...

Mineralocorticoid receptor antagonists (MRAs) reduced the risk of cardiovascular death or heart failure (HF) hospitalization ...

The weight-loss jab Wegovy has been hailed as an “absolute game-changer” after a new study showed that it relieved symptoms ...

Heart failure during pregnancy is a dangerous and often under-detected condition because common symptoms – shortness of breath, extreme fatigue and trouble breathing while lying down – are easily ...

The medication, finerenone, could be an effective therapy in people with heart failure who have mildly reduced or preserved ejection fraction, suggests the study, published Sunday in the New England ...

Can weight loss medications trigger a thyroid crisis? In this case, rapid weight loss from tirzepatide led to ...

This meta-analysis investigated the effects of mineralocorticoid receptor antagonists (MRAs) using data from nearly 14,000 patients with heart failure (HF) from four trials.  MRAs reduced the risk of ...